
Valenty10 mg
Eskayef Bangladesh Ltd.
Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction (ED) in adult men.
Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction (ED) in adult men. This is the sole FDA-approved and internationally recognized indication for Vardenafil.
Vardenafil is not indicated for use in women or children, and it does not increase sexual desire; it works only in the presence of sexual stimulation.
| Population | Recommended Dose |
|---|---|
| General adult starting dose | 10 mg orally, approximately 60 minutes before anticipated sexual activity |
| Dose adjustment range | May be increased to 20 mg or decreased to 5 mg based on individual efficacy and tolerability |
| Maximum dosing frequency | Once per day (maximum one dose in 24 hours) |
| Elderly (≥65 years) | Consider starting at the lowest dose (5 mg) |
| Hepatic impairment (mild, Child-Pugh A) | No dose adjustment required |
| Hepatic impairment (moderate, Child-Pugh B) | Start at 5 mg; maximum recommended dose 10 mg |
| Hepatic impairment (severe, Child-Pugh C) | Not recommended — not adequately studied |
| Renal impairment (mild–moderate) | No dose adjustment required |
| Renal impairment (severe, CrCl <30 mL/min) or dialysis | Start at 5 mg with caution |
| Pediatric use | Not indicated; safety and efficacy not established |
Vardenafil should be taken as a single dose; sexual stimulation is required for effectiveness. Do not take more than one dose of Vardenafil per day. Do not use Vardenafil together with any other PDE5 inhibitor or with organic nitrates (see Contraindications).
Most adverse effects of Vardenafil are mild to moderate and transient.
Vardenafil is contraindicated in the following situations:
Use of Vardenafil is not recommended in men for whom sexual activity is inadvisable due to underlying cardiovascular status (e.g., recent myocardial infarction or stroke within the last 6 months, unstable angina, uncontrolled arrhythmias, severe heart failure) or in those with severe hepatic impairment — these are important cautions to be assessed by a physician rather than absolute contraindications.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.